Annual SG&A
$88.41M$22.06M+33.25%
Summary
- Current Value
- As of today, ACLX annual SG&A is $88.41M, up +33.25% on
- Historical Performance
- ACLX annual SG&A is up +387.53% over the past 3 years, and up +3904.26% over the past 5 years
- All-Time High Comparison
- ACLX annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- ACLX annual SG&A is +112.00% above its 3-year low of $41.70M reached on an earlier date
- Sector Comparison
- ACLX annual SG&A is higher than 81.51% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $88.41M | +33.3% | +387.5% | +3904.3% | +3904.3% | |
| Quarterly SG&A | $31.64M | +54.5% | +204.1% | +1356.6% | +1356.6% | |
| TTM SG&A | -$2.34B | -2880.0% | -6782.8% | -10000.0% | -10000.0% | |
| Price | $67.23 | +2.8% | +103.7% | – | – | |
| Annual Operating Expenses | $245.51M | +22.6% | +277.6% | +1265.9% | +1265.9% | |
| Annual Operating Profit | -$137.57M | -53.1% | -111.6% | -665.4% | -665.4% | |
| Annual D&A | $5.19M | +154.3% | +398.4% | +1491.4% | +1491.4% | |
| Annual Revenue | $107.94M | -2.2% | +100.0% | +100.0% | +100.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $88.41M | at high | |
| 5Y | $88.41M | at high | |
| All | $88.41M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $41.70M | N/A | +112.0% |
| 5Y | $7.04M | N/A | +1155.9% |
| All | $2.21M | +3904.3% |
SG&A History
| Year | Value | Change |
|---|---|---|
| $88.41M | +33.3% | |
| $66.35M | +59.1% | |
| $41.70M | +130.0% |
| Year | Value | Change |
|---|---|---|
| $18.14M | +157.6% | |
| $7.04M | +218.8% | |
| $2.21M | - |
FAQ
What is the current annual SG&A of ACLX?
As of today, ACLX annual SG&A is $88.41M
What is 1-year change in ACLX annual SG&A?
ACLX annual SG&A is up +33.25% year-over-year
What is 3-year change in ACLX annual SG&A?
ACLX annual SG&A is up +387.53% over the past 3 years
How far is ACLX annual SG&A from its all-time high?
ACLX annual SG&A is currently at its all-time high
How does ACLX annual SG&A rank versus sector peers?
ACLX annual SG&A is higher than 81.51% of companies in Healthcare sector
When is ACLX next annual earnings release?
The next annual earnings release for ACLX is on
Quarterly SG&A
$31.64M$2.98M+10.41%
Summary
- Current Value
- As of today, ACLX quarterly SG&A is $31.64M, up +10.41% on
- Historical Performance
- ACLX quarterly SG&A is up +54.53% year-over-year, and up +204.14% over the past 3 years
- All-Time High Comparison
- ACLX quarterly SG&A is currently at its all-time high
- 3-Year Low Comparison
- ACLX quarterly SG&A is +125.00% above its 3-year low of $14.06M reached on an earlier date
- Sector Comparison
- ACLX quarterly SG&A is higher than 82.47% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $31.64M | +10.4% | +54.5% | +204.1% | +1356.6% | |
| Annual SG&A | $88.41M | – | +33.3% | +387.5% | +3904.3% | |
| TTM SG&A | -$2.34B | -2456.2% | -2880.0% | -6782.8% | -10000.0% | |
| Price | $67.23 | -20.0% | +2.8% | +103.7% | – | |
| Quarterly Operating Expenses | $64.88M | +0.3% | +11.3% | -30.4% | +626.6% | |
| Quarterly Operating Profit | -$61.78M | -5.2% | -83.8% | +34.2% | -579.3% | |
| Quarterly D&A | $1.84M | +13.9% | +38.2% | +179.2% | – | |
| Quarterly Revenue | $4.95M | -34.5% | -81.0% | +100.0% | +100.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $31.64M | at high | |
| 3Y | $31.64M | at high | |
| 5Y | $31.64M | at high | |
| All | $31.64M | at high |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $23.77M | N/A | +33.1% |
| 3Y | $14.06M | N/A | +125.0% |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of ACLX?
As of today, ACLX quarterly SG&A is $31.64M
What is ACLX quarterly SG&A most recent change?
ACLX quarterly SG&A was up +10.41% on September 30, 2025
What is 1-year change in ACLX quarterly SG&A?
ACLX quarterly SG&A is up +54.53% year-over-year
How far is ACLX quarterly SG&A from its all-time high?
ACLX quarterly SG&A is currently at its all-time high
How does ACLX quarterly SG&A rank versus sector peers?
ACLX quarterly SG&A is higher than 82.47% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
TTM SG&A
-$2.34B$217.90M-10.29%
Summary
- Current Value
- As of today, ACLX TTM SG&A is -$2.34B, down -10.29% on
- Historical Performance
- ACLX TTM SG&A is down -2879.96% year-over-year, and down -6782.82% over the past 3 years
- All-Time High Comparison
- ACLX TTM SG&A is currently -3485.16% below its historical high of -$65.14M set on an earlier date
- 3-Year Low Comparison
- ACLX TTM SG&A is at its 3-year low
- Sector Comparison
- ACLX TTM SG&A is higher than 23.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | -$2.34B | -2456.2% | -2880.0% | -6782.8% | -10000.0% | |
| Annual SG&A | $88.41M | – | +33.3% | +387.5% | +3904.3% | |
| Quarterly SG&A | $31.64M | +10.4% | +54.5% | +204.1% | +1356.6% | |
| Price | $67.23 | -20.0% | +2.8% | +103.7% | – | |
| TTM Operating Profit | -$242.55M | -13.1% | -249.4% | -41.1% | -2567.2% | |
| TTM D&A | $6.83M | +8.1% | +65.6% | +356.0% | – | |
| TTM Revenue | $35.90M | -37.0% | -77.0% | +100.0% | +100.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$1.77B | N/A | -32.2% |
| 3Y | -$941.66M | N/A | -148.0% |
| 5Y | -$65.14M | N/A | -3485.2% |
| All | -$65.14M | N/A | -3485.2% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.34B | N/A | at low |
| 3Y | -$2.34B | N/A | at low |
| 5Y | -$2.34B | N/A | at low |
| All | -$2.34B | N/A | at low |
TTM SG&A History
FAQ
What is the current TTM SG&A of ACLX?
As of today, ACLX TTM SG&A is -$2.34B
What is ACLX TTM SG&A most recent change?
ACLX TTM SG&A was down -10.29% on September 30, 2025
What is 1-year change in ACLX TTM SG&A?
ACLX TTM SG&A is down -2879.96% year-over-year
How does ACLX TTM SG&A rank versus sector peers?
ACLX TTM SG&A is higher than 23.25% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- ACLX Official Website www.arcellx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1786205/000119312525266932/0001193125-25-266932-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1786205/000095017025029150/0000950170-25-029150-index.htm
- ACLX Profile on Yahoo Finance finance.yahoo.com/quote/ACLX
- ACLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aclx